An Exploratory Study to Evaluate the Effects of Roflumilast on Insulin Sensitivity and Metabolic Parameters in Prediabetic Overweight and Obese Individuals
Phase of Trial: Phase I/II
Latest Information Update: 25 Oct 2017
At a glance
- Drugs Roflumilast (Primary)
- Indications Obesity; Prediabetic-state
- Focus Pharmacodynamics
- 26 Jul 2017 Status changed from recruiting to completed.
- 07 Apr 2017 Planned primary completion date changed from 30 Mar 2017 to 30 Sep 2018.
- 02 Aug 2016 Planned End Date changed from 1 Sep 2016 to 1 Sep 2018.